<i>Ad interim</i> recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group-Reference-Cited by-同舟云学术

Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

Published:2022-04-22 Issue:7 Volume:60 Page:975-981
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Lippi Giuseppe¹²³^ORCID,Favresse Julien¹⁴,Gromiha Michael M.¹⁵,SoRelle Jeffrey A.¹⁶,Plebani Mario¹⁷^ORCID,Henry Brandon M.¹⁸

Affiliation:

1. IFCC SARS-CoV-2 Variants Working Group , Verona , Italy

2. IFCC Task Force on COVID-19 , Verona , Italy

3. Section of Clinical Biochemistry and School of Medicine, University of Verona , Verona , Italy

4. Department of Laboratory Medicine , Clinique St-Luc Bouge , Namur , Belgium

5. Department of Biotechnology , Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras , Chennai , India

6. Department of Pathology , University of Texas Southwestern Medical Center , Dallas , TX , USA

7. Department of Medicine-DIMED , University of Padova , Padova , Italy

8. Clinical Laboratory, Division of Nephrology and Hypertension , Cincinnati Children’s Hospital Medical Center , Cincinnati , OH , USA

Abstract

Abstract This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to update previous indications for diagnosing acute SARS-CoV-2 infection, taking into consideration the evidence that has emerged after the origin and spread of new lineages and sub-lineages of the virus characterized by mutated genetics and altered biochemical, biological and clinical characteristics. These indications encompass the use of different diagnostic strategies in specific clinical settings, such as high risk of SARS-CoV-2 infection (symptomatic patients), low risk of SARS-CoV-2 infection (asymptomatic subjects) at hospital admission/contact tracing, testing in asymptomatic subjects, in epidemiologic surveys and/or population screening, along with tentative indications for identification of new lineages and/or sub-lineages of SARS-CoV-2.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2022-0345/pdf

Reference39 articles.

1. Lippi, G, Mattiuzzi, C, Henry, BM. Updated picture of SARS-CoV-2 variants and mutations. Diagnosis 2022;9:11–7. https://doi.org/10.1515/dx-2021-0149.

2. Lippi, G, Henry, BM. The landscape of SARS-CoV-2 genomic mutations. J Lab Precis Med 2022. https://doi.org/10.21037/jlpm-22-17 [Epub ahead of print].

3. Bohn, MK, Mancini, N, Loh, TP, Wang, CB, Grimmler, M, Gramegna, M, et al.. IFCC interim guidelines on molecular testing of SARS-CoV-2 infection. Clin Chem Lab Med 2020;58:1993–2000. https://doi.org/10.1515/cclm-2020-1412.

4. World health Organization. Diagnostic testing for SARS-CoV-2. Available at: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2 [Last accessed 1 Apr 2022].

5. US Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2, the virus that causes COVID-19 - updated Feb. 11, 2022. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html#TestingInfection [Last accessed 1 Apr 2022].

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples;Clinical Chemistry and Laboratory Medicine (CCLM);2023-10-04

2. Efficiency evaluation of a SARS-CoV-2 diagnostic strategy combining high throughput quantitative antigen immunoassay and real time PCR;Clinical Chemistry and Laboratory Medicine (CCLM);2023-03-22

3. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay;Clinical Chemistry and Laboratory Medicine (CCLM);2023-03-08

4. Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing;Clinical Chemistry and Laboratory Medicine (CCLM);2023-02-28

5. Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection;Diagnosis;2023-02-20